Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-08-31FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ranitidine by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial comparing dexlansoprazole MR to placebo to maintain healing in subjects with healed erosive esophagitis; results posted in 200…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR vs placebo in maintaining healing in patients with healed erosive eso…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating dexlansoprazole MR for maintaining healing in subjects with previously healed erosive esophagitis; results and safe…
-
FDA approval · 2009-07-31FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add the Solutab dosage form to the approved product line. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-06-18FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the la…
-
FDA approval · 2009-04-02FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole), enabling continued marketing of the product unde…
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis [Phase 4]
Phase 4 multicenter, randomized, double-dummy trial comparing esomeprazole magnesium 40 mg daily to lansoprazole 30 mg daily for healing of …
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis [Phase 4]
Phase 4 trial update completed evaluating Nexium (esomeprazole) for moderate to severe erosive esophagitis and related reflux conditions.
-
CLINICAL_TRIALS trial_result · 2009-03-26Clinical Trial Update: Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed [Phase 4]
A Phase 4 multicenter, randomized, double-blind, double-dummy trial comparing once-daily esomeprazole 20 mg to lansoprazole 15 mg for six mo…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR and Lansoprazole for healing erosive esophagitis; results have been p…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dexlansoprazole MR and Lansoprazole for healing erosive esophagitis; results were posted…
-
FDA approval · 2009-02-27FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.
-
FDA approval · 2009-01-30FDA Approved: DEXILANT — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved Dexilant (dexlansoprazole) under an original application for the treatment of gastroesophageal reflux disease, including healin…
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for omeprazole filed by Quallent Pharmaceuticals Health LLC under an ANDA.
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Original Application (Sandoz Inc)
FDA approved the original application for omeprazole from Sandoz Inc, authorizing a generic version of this proton pump inhibitor.
-
FDA approval · 2008-12-01FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) by Covis Pharma US, Inc. to update and/or expand the product lab…
-
FDA approval · 2008-11-24FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
FDA approved a supplemental application for ACID CONTROLLER (famotidine) from H E B. The approval expands the product's labeling/indications…
-
FDA approval · 2008-06-30FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2008-06-25FDA Approved: FAMOTIDINE — Original Application (Mylan Institutional LLC)
The FDA approved a generic famotidine product from Mylan Institutional LLC under an original ANDA.
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved Sagent Pharmaceuticals' supplemental application for famotidine under an existing ANDA, updating the product's approved lab…
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for famotidine from Sagent Pharmaceuticals, confirming the generic product under ANDA075651.
-
FDA approval · 2008-05-20FDA Approved: FAMOTIDINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for famotidine (Hikma Pharmaceuticals USA Inc.). The approval updates the labeling to reflect additi…
-
FDA approval · 2008-04-21FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID (lansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-21FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for PREVACID SOLUTAB (lansoprazole) filed by Takeda Pharmaceuticals America, expanding the product's…